Visceral abdominal and subfascial femoral adipose tissue have opposite associations with liver fat in overweight and obese premenopausal caucasian women
- PMID: 21961071
- PMCID: PMC3179871
- DOI: 10.1155/2011/154672
Visceral abdominal and subfascial femoral adipose tissue have opposite associations with liver fat in overweight and obese premenopausal caucasian women
Abstract
Abdominal obesity has been associated with liver fat storage. However, the relationships between other body composition depots and metabolic syndrome features with hepatic fat are still unclear. We examined abdominal and thigh adipose tissue (AT) compartments associations with liver fat in 140 overweight and obese premenopausal Caucasian women. Blood lipids and, proinflammatory and atherothrombotic markers associations with hepatic fat were also analyzed. A larger visceral AT (VAT) was related with liver fat (P < 0.05). Contrarily, thigh subfascial AT was inversely related to liver fat (P < 0.05). Increased fasting insulin, triglycerides, PAI-1 concentrations, and a higher total-cholesterol/HDL-cholesterol ratio were also associated with hepatic fat, even after adjustment for VAT (P < 0.05). Thigh subfascial adiposity was inversely associated with liver fat, suggesting a potential preventive role against ectopic fat storage in overweight and obese women. These results reinforce the contribution of an abdominal obesity phenotype associated with a diabetogenic and atherothrombotic profile to liver lipotoxicity.
Similar articles
-
Independent and opposite associations of hip and waist circumference with metabolic syndrome components and with inflammatory and atherothrombotic risk factors in overweight and obese women.Metabolism. 2008 Oct;57(10):1315-22. doi: 10.1016/j.metabol.2008.01.003. Metabolism. 2008. PMID: 18803932
-
Relationship of visceral adipose tissue to metabolic risk factors for coronary heart disease: is there a contribution of subcutaneous fat cell hypertrophy?Metabolism. 1999 Mar;48(3):355-62. doi: 10.1016/s0026-0495(99)90085-9. Metabolism. 1999. PMID: 10094113 Clinical Trial.
-
Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.Metabolism. 2001 Apr;50(4):425-35. doi: 10.1053/meta.2001.21693. Metabolism. 2001. PMID: 11288037 Clinical Trial.
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
-
The regulation of adipose tissue distribution in humans.Int J Obes Relat Metab Disord. 1996 Apr;20(4):291-302. Int J Obes Relat Metab Disord. 1996. PMID: 8680455 Review.
Cited by
-
What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?World J Gastroenterol. 2013 Feb 14;19(6):802-12. doi: 10.3748/wjg.v19.i6.802. World J Gastroenterol. 2013. PMID: 23430039 Free PMC article. Review.
-
Effect of focused ultrasound cavitation augmented with aerobic exercise on abdominal and intrahepatic fat in patients with non-alcoholic fatty liver disease: A randomized controlled trial.PLoS One. 2021 Apr 28;16(4):e0250337. doi: 10.1371/journal.pone.0250337. eCollection 2021. PLoS One. 2021. PMID: 33909662 Free PMC article. Clinical Trial.
-
Appetite regulation and weight control: the role of gut hormones.Nutr Diabetes. 2012 Jan 16;2(1):e26. doi: 10.1038/nutd.2011.21. Nutr Diabetes. 2012. PMID: 23154682 Free PMC article.
-
Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease.J Obes Metab Syndr. 2022 Mar 30;31(1):17-27. doi: 10.7570/jomes22021. J Obes Metab Syndr. 2022. PMID: 35332111 Free PMC article. Review.
-
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.Medicines (Basel). 2019 Mar 18;6(1):41. doi: 10.3390/medicines6010041. Medicines (Basel). 2019. PMID: 30889791 Free PMC article. Review.
References
-
- Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. The American Journal of Physiology—Endocrinology and Metabolism. 2000;278(5):E941–E948. - PubMed
-
- Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B, small, dense LDL) in men? Circulation. 2000;102(2):179–184. - PubMed
-
- Després JP. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients’ risk. Obesity Research. 1998;6(supplement 1):8S–17S. - PubMed
-
- Ross R, Aru J, Freeman J, Hudson R, Janssen I. Abdominal adiposity and insulin resistance in obese men. The American Journal of Physiology—Endocrinology and Metabolism. 2002;282:E657–E663. - PubMed
-
- Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY. Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes. 1990;39(1):104–111. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous